# Eyebright Medical Successfully Concludes Participation in Hong Kong International Optical Fair 2026

- Link: https://www.thailand-business-news.com/pr-news/eyebright-medical-successfully-concludes-participation-in-hong-kong-international-optical-fair-2026
- Published: 2026-11-13T10:44:00+07:00
- Author: PR Newswire

**LeBleu® and KAMIYA Make Debut in Hong Kong, Drawing Widespread Industry Attention**

HONG KONG, Nov. 13, 2026 /PRNewswire/ — Eyebright Medical Technology (Beijing) Co.,
Ltd. (referred to as "Eyebright Medical", Stock Code: 688050.SH) completed its participation
in the Hong Kong International Optical Fair 2026. Held from November 4 to 6, 2026,
at the Hong Kong Convention and Exhibition Centre, the fair serves as a trade event
for the optometry and eyewear industry, bringing together global buyers, eye care
professionals, and brand representatives as a platform for technology exchange and
international channel expansion.

[[

At this year’s exhibition, Eyebright Medical presented its vision care brand portfolio.
Driven by the steady growth of the group’s vision care sector, the dual brands LeBleu
® and KAMIYA made a simultaneous appearance, showcasing Eyebright Medical’s end-
to-end R&D, manufacturing, and sales capabilities to partners across the Asia-Pacific
region.

As Eyebright Medical’s representative brand for contact lenses, LeBleu® incorporates
the group’s R&D capabilities in optical design and manufacturing. Backed by Eyebright
Medical’s R&D team of over 300 professionals and two self-owned, GMP-certified smart
manufacturing bases — Jiangsu Tianyan Medical and Fujian Evercon, with a combined
standardized R&D and production space of over 120,000 square meters. LeBleu® maintains
end-to-end control over material R&D, optical design, manufacturing, and quality
control, safeguarding product stability and wearing safety at the source.

LeBleu® presented several product series at the fair, including silicone hydrogel
series, EDF aspheric daily disposable contact lenses, EDF+ high-order aspheric bi-
weekly and half-year disposable contact lenses, and Toric color contact lenses. 
The product line incorporates Extended Depth of Focus (EDF) aspheric optical design
alongside storage solution formulations containing Vitamin B12 and Hyaluronic Acid
tailored for daily wear.

Sharing the spotlight was KAMIYA, an emerging color contact lens brand, which showcased
its Spotlight Series Toric Color Contact Lenses in their Hong Kong debut. As Eyebright
Medical’s brand in the color lens segment, KAMIYA focuses on consumer preferences
for fashion aesthetics and product value. Supported by Eyebright Medical’s manufacturing
infrastructure and digital quality control, KAMIYA maintains batch-level product
traceability. Furthermore, utilizing high-speed AOI optical inspection systems and
supply chain management, KAMIYA optimizes its cost structure to deliver accessible
pricing.

The sample trial sessions during the exhibition generated strong interest. Channel
partners from Hong Kong, Macao, and Southeast Asia inquired about product registration,
packaging localization, and market promotion strategies, evaluating the commercial
potential of color lens brands among young Asia-Pacific consumers.

Eyebright Medical’s participation attracted media coverage and on-site interviews.
Mr. Jia Baoshan, Deputy General Manager and Sales and Market Sales Director of Eyebright
Medical Technology (Beijing) Co., Ltd., together with Ms. Zhou Yuxi, General Manager
of Eyebright Medical’s Hong Kong subsidiary, jointly participated in media interviews
and shared the group’s operational developments, outlining Eyebright Medical’s international
growth orientation and overall business structure. The organizer, Hong Kong Trade
Development Council, also highlighted Eyebright Medical as an exhibitor case study
across official event communications.

[⌊Mr. Jia Baoshan, Deputy General Manager and Sales and Market Sales Director of
Eyebright Medical Technology (Beijing) Co., Ltd alongside with Ms.Zhou Yuxi, General
Manager of Eyebright Medical’s Hong Kong subsidiary⌉⌊Mr. Jia Baoshan, Deputy General
Manager and Sales and Market Sales Director of Eyebright Medical Technology (Beijing)
Co., Ltd alongside with Ms.Zhou Yuxi, General Manager of Eyebright Medical’s Hong
Kong subsidiary⌉[
Mr. Jia Baoshan, Deputy General Manager and Sales and Market Sales
Director of Eyebright Medical Technology (Beijing) Co., Ltd alongside with Ms.Zhou
Yuxi, General Manager of Eyebright Medical’s Hong Kong subsidiary

As an international hub connecting Mainland China with global markets, Hong Kong
serves as a strategic node for Eyebright Medical’s regional roadmap. Leveraging 
Hong Kong’s business network and regulatory framework, Eyebright Medical’s local
team continues to advance international registration, academic engagement, and channel
development across its vision care and ophthalmic device portfolios.

**About Eyebright Medical Technology (Beijing) Co., Ltd.**

Eyebright Medical Technology (Beijing) Co., Ltd. is listed on the STAR Market of
the Shanghai Stock Exchange (Stock Abbreviation: Eyebright Medical, Stock Code: 
688050.SH). Located in Zhongguancun Science Park, Beijing, it is a National High-
Tech Enterprise and a recognized National "Little Giant" Enterprise specializing
in niche markets. As an innovation-driven high-end medical device manufacturer with
a global vision, Eyebright Medical has strategically laid out its presence across
four high-potential sectors: ophthalmic surgical treatments, myopia management, 
consumer vision care, and sports medicine. Leveraging deep technical barriers and
robust commercialization capabilities, the company is positioning itself among global
medical technology leaders as a representative of China’s intelligent manufacturing
strength.

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [Eyebright Medical Successfully Concludes Participation in Hong Kong International Optical Fair 2026 ](https://en.prnasia.com/story/archive/5097036_AE97036_0?rand=184833)
